Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Calidi Biotherapeutics is a clinical-stage biotechnology company developing immunotherapies for cancer.
ImmunoVec develops gene therapy treatments to cure terminal genetic diseases of the immune system.
Rejuvenate Bio is a biotechnology company that develops therapies to reverse aging and treat age-related diseases.
AcuraStem harnesses human, patient-specific in vitro cell models and assays to develop cures and improve diagnoses in disorders of the CNS.
Entos Pharmaceuticals is a clinical-stage biotech company developing genetic medicines with its Fusogenix PLV drug delivery platform.
Cure Rare Disease is a biotechnology company.
Tr1x is a biotechnology company developing novel cellular immunotherapies for patients with autoimmune and inflammatory diseases.
Angiocrine Bioscience develops a cellular platform to amplify stem and progenitor cells in both human and mouse models.
Mahzi Therapeutics is a health care and biotechnology company.
Aspera Biomedicines is a space-accelerated biotechnology company pioneering therapies that target cancer stem cells.
Blue Gen Therapeutics Foundation is a non-profit clinical-stage biotech organization.
Mustang Bio is a clinical-stage biopharmaceutical company .
Navega Therapeutics is a preclinical stage company developing epigenetic gene therapies for neurological and ophthalmic diseases.
Amplo Biotechnology is to develop multiple, potentially curative, Adeno-Associated Viral (AAV) therapies for the neuromuscular junction.
NysnoBio helps patients with medical conditions develop the Parkin protein's therapeutic potential.
Lutris Pharma develops drugs to improve anti-cancer therapy effectiveness.
Rocket Pharmaceuticals is a biotech company that develops a pipeline of genetic therapies for rare childhood disorders.
Nexcella Utilize cell therapies to create safe and effective medicines for oncology and other conditions, improving patient outcomes.
Luxa Biotechnology is a clinical-stage biotechnology firm developing a unique adult RPE stem cell (RPESC) therapy for dry AMD.
Anova Enterprises accelerates clinical development of promising therapeutics through improved access, collaboration and data.
Denovo Biopharma is a privately held biotech company providing a novel biomarker solution to personalize drug development.
Kenai Therapeutics focuses on developing therapies for neurodegenerative movement disorders.
Cytonus is a biotech company combining AI-driven drug discovery together with a class defining drug-delivery platform called the Cargocyte
Greenstone Biosciences is a drug discovery platform that accelerates the development of effective therapies for patients.
California Institute for Regenerative Medicine has invested in 49 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
California Institute for Regenerative Medicine's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Biopharma. The firm invests across 18 different industry categories.
Among tracked funding rounds, Rocket Pharmaceuticals received $165.0M in a Post-IPO Equity round. California Institute for Regenerative Medicine's total known invested capital is $854.6M.
California Institute for Regenerative Medicine's average investment size is $17.4M across its portfolio of 49 companies.
Recent California Institute for Regenerative Medicine portfolio additions include Calidi Biotherapeutics, ImmunoVec, Rejuvenate Bio, AcuraStem, Entos Pharmaceuticals. These companies were founded in 2020 or later.